Incyte is a global biopharmaceutical company that is focused on finding solutions for serious
unmet medical needs through the discovery, development and commercialization of novel medicines.
Since 2002, Incyte has remained committed to the relentless pursuit of science that can improve
the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders.
The Company is advancing a diversified portfolio of clinical candidates across Oncology and Inflammation & Autoimmunity.